7月3日中欧医疗健康混合C净值增长1.50%，近6个月累计上涨14.38%

Group 1 - The core viewpoint of the news is the performance and holdings of the China Europe Medical Health Mixed Fund C, which has shown positive growth in recent months and has a significant concentration in its top ten stock holdings [1][3] - As of July 3, 2025, the latest net value of the fund is 1.6642 yuan, reflecting a growth of 1.50%. The fund's one-month return is 1.53%, six-month return is 14.38%, and year-to-date return is 10.32% [1] - The fund's top ten stock holdings account for a total of 55.30%, with significant positions in companies such as Heng Rui Pharmaceutical (10.60%), WuXi AppTec (9.95%), and Mindray Medical (5.21%) [1] Group 2 - The China Europe Medical Health Mixed Fund C was established on September 29, 2016, and as of March 31, 2025, it has a total scale of 15.566 billion yuan [1] - The fund manager, Ge Lan, has a background in biomedical engineering and has held various positions in research and fund management since joining China Europe Fund Management in October 2014 [2]